Larvol Delta - Biodexa--An-Adaptive-Design-Study-of-MTX228

tolimidone (MTX228) - Bukwang Pharma, Biodexa Pharma

http://clinicaltrials.gov/ct2/show/NCT06474598

Jun 25, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next